Vaccination of healthy children against seasonal influenza: A european perspective

Pediatric Infectious Disease Journal

Volumn 32, Issue 8, 2013, Pages 881-888

  Heikkinen, Terho ^a   Tsolia, Maria ^b   Finn, Adam ^c  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

children; immunization; influenza; vaccine

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ACUTE OTITIS MEDIA; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG SAFETY; FEBRILE CONVULSION; HEALTH CARE DELIVERY; HEMAGGLUTINATION INHIBITION; HOSPITALIZATION; HUMAN; IMMUNE RESPONSE; INFLUENZA VACCINATION; MORTALITY; NARCOLEPSY; PANDEMIC INFLUENZA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEASONAL INFLUENZA;

CHILD, PRESCHOOL; COST OF ILLNESS; COST-BENEFIT ANALYSIS; EUROPE; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MASS VACCINATION;

EID: 84880604631     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182918168     Document Type: Review

References (105)

1. McIntosh K, Lieu T. Is it time to give influenza vaccine to healthy infants? N Engl J Med. 2000;342:275-276.
2. Neuzil KM, Mellen BG, Wright PF, et al. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med. 2000;342:225-231.
3. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 2000;342:232-239.
4. Bridges CB, Harper SA, Fukuda K, et al.; Advisory Committee on Immunization Practices. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2003;52(RR-8):1-34; quiz CE1
5. National Advisory Committee on Immunization. Statement on influenza vaccination for the 2003-2004 season. Can Commun Dis Rep. 2003;29:1-20.
6. Fiore AE, Uyeki TM, Broder K, et al.; Centers for Disease Control and Prevention. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep. 2010;59(RR-8):1-62.
7. Centers for Disease Control and Prevention. Flu vaccination coverage, United States, 2011-12 influenza season. Available at: http://www.cdc.gov/flu/ professionals/vaccination/coverage-1112estimates.htm Accessed February 26, 2013.
8. Heikkinen T, Booy R, Campins M, et al. Should healthy children be vaccinated against influenza? A consensus report of the Summits of Independent European Vaccination Experts. Eur J Pediatr. 2006;165:223-228.
9. Usonis V, Anca I, André F, et al. Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for influenza vaccination in children. BMC Infect Dis. 2010;10:168.
10. Mereckiene J, Cotter S, D́Ancona F, et al. Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008-2009. Euro Surveill. 2010;15(44):pii=19700. Available at: http://www.eurosurveillance. org/ViewArticle.aspx?ArticleId=19700 Accessed February 26, 2013.
11. Blank PR, Schwenkglenks M, Szucs TD. Vaccination coverage rates in eleven European countries during two consecutive influenza seasons. J Infect. 2009;58:446-458.
12. Rance F, Chave C, De Blic J, et al. Low influenza vaccination coverage in asthmatic children in France in 2006-7. Euro Surveill. 2008;13:19016.
13. European Centre for Disease Prevention and Control. Vaccination schedules. Available at: http://ecdc.europa.eu/en/activities/surveillance/euvac/ schedules/Pages/schedules.aspx Accessed February 26, 2013.
14. Joint Committee on Vaccination and Immunisation. JCVI statement on the annual influenza vaccination programme-extension of the programme to children, 25 July 2012. Available at: http://www.wp.dh.gov.uk/transparency/files/2012/07/ JCVI-statement-on-the-annual-influenza-vaccinationprogramme-25-July-2012.pdf Accessed February 26, 2013.
15. European Centre for Disease Prevention and Control. New WHO recommendations on seasonal influenza immunization from the Strategic Advisory Group of Experts on Immunization (SAGE)-adding pregnant women as the highest priority and consideration of immunizing children aged 6 months to 5 years. Available at: http://www.ecdc.europa.eu/en/activities/sciadvice/Lists/EC DC%20Reviews/EC DC-DispForm.aspx?List=512ff74f-77d4-4ad8-b6d6- bf0f23083f30&ID=1271 Accessed February 26, 2013.
16. Neuzil KM, Zhu Y, Griffin MR, et al. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis. 2002;185:147-152.
17. Glezen WP, Couch RB. Interpandemic influenza in the Houston area, 1974-76. N Engl J Med. 1978;298:587-592.
18. Monto AS, Sullivan KM. Acute respiratory illness in the community. Frequency of illness and the agents involved. Epidemiol Infect. 1993;110:145-160.
19. Heikkinen T, Silvennoinen H, Peltola V, et al. Burden of influenza in children in the community. J Infect Dis. 2004;190:1369-1373.
20. Hurwitz ES, Haber M, Chang A, et al. Studies of the 1996-1997 inactivated influenza vaccine among children attending day care: immunologic response, protection against infection, and clinical effectiveness. J Infect Dis. 2000;182:1218-1221.
21. Heikkinen T, Ziegler T, Peltola V, et al. Incidence of influenza in Finnish children. Pediatr Infect Dis J. 2003;22(suppl 10):S204-S206.
22. Nair H, Brooks WA, Katz M, et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and metaanalysis. Lancet. 2011;378:1917-1930.
23. Weigl JA, Puppe W, Schmitt HJ. The incidence of influenza-associated hospitalizations in children in Germany. Epidemiol Infect. 2002;129:525-533.
24. Rojo JC, Ruiz-Contreras J, Fernández MB, et al. Influenza-related hospitalizations in children younger than three years of age. Pediatr Infect Dis J. 2006;25:596-601.
25. Sakkou Z, Stripeli F, Papadopoulos NG, et al. Impact of influenza infection on children's hospital admissions during two seasons in Athens, Greece. Vaccine. 2011;29:1167-1172.
26. Ploin D, Liberas S, Thouvenot D, et al. Influenza burden in children newborn to eleven months of age in a pediatric emergency department during the peak of an influenza epidemic. Pediatr Infect Dis J. 2003;22(suppl 10):S218-S222.
27. Montes M, Vicente D, Pérez-Yarza EG, et al. Influenza-related hospitalizations among children aged less than 5 years old in the Basque Country, Spain: a 3-year study (July 2001-June 2004). Vaccine. 2005;23:4302-4306.
28. Poehling KA, Edwards KM, Weinberg GA, et al.; New Vaccine Surveillance Network. The underrecognized burden of influenza in young children. N Engl J Med. 2006;355:31-40.
29. Ajayi-Obe EK, Coen PG, Handa R, et al. Influenza A and respiratory syncytial virus hospital burden in young children in East London. Epidemiol Infect. 2008;136:1046-1058.
30. Silvennoinen H, Peltola V, Vainionpää R, et al. Incidence of influenzarelated hospitalizations in different age groups of children in Finland: a 16-year study. Pediatr Infect Dis J. 2011;30:e24-e28.
31. Ampofo K, Gesteland PH, Bender J, et al. Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection. Pediatrics. 2006;118:2409-2417.
32. Dawood FS, Fiore A, Kamimoto L, et al.; Emerging Infections Program Network. Burden of seasonal influenza hospitalization in children, United States, 2003 to 2008. J Pediatr. 2010;157:808-814.
33. Silvennoinen H, Peltola V, Vainionpää R, et al. Admission diagnoses of children 0-16 years of age hospitalized with influenza. Eur J Clin Microbiol Infect Dis. 2012;31:225-231.
34. Pitman RJ, Melegaro A, Gelb D, et al. Assessing the burden of influenza and other respiratory infections in England and Wales. J Infect. 2007;54:530-538.
35. Quach C, Piché-Walker L, Platt R, et al. Risk factors associated with severe influenza infections in childhood: implication for vaccine strategy. Pediatrics. 2003;112(3 Pt 1):e197-e201.
36. Heikkinen T. Influenza in children. Acta Paediatr. 2006;95:778-784.
37. Glezen WP, Decker M, Joseph SW, et al. Acute respiratory disease associated with influenza epidemics in Houston, 1981-1983. J Infect Dis. 1987;155:1119-1126.
38. Silvennoinen H, Peltola V, Lehtinen P, et al. Clinical presentation of influenza in unselected children treated as outpatients. Pediatr Infect Dis J. 2009;28:372-375.
39. Ruuskanen O, Arola M, Putto-Laurila A, et al. Acute otitis media and respiratory virus infections. Pediatr Infect Dis J. 1989;8:94-99.
40. Heikkinen T, Ruuskanen O, Waris M, et al. Influenza vaccination in the prevention of acute otitis media in children. Am J Dis Child. 1991;145:445-448.
41. Peltola V, Ziegler T, Ruuskanen O. Influenza A and B virus infections in children. Clin Infect Dis. 2003;36:299-305.
42. Laundy M, Ajayi-Obe E, Hawrami K, et al. Influenza A communityacquired pneumonia in East London infants and young children. Pediatr Infect Dis J. 2003;22(suppl 10):S223-S227.
43. Dawood FS, Fiore A, Kamimoto L, et al. Influenza-associated pneumonia in children hospitalized with laboratory-confirmed influenza, 2003-2008. Pediatr Infect Dis J. 2010;29:585-590.
44. Lahti E, Peltola V, Virkki R, et al. Influenza pneumonia. Pediatr Infect Dis J. 2006;25:160-164.
45. Clements DA, Langdon L, Bland C, et al. Influenza A vaccine decreases the incidence of otitis media in 6-to 30-month-old children in day care. Arch Pediatr Adolesc Med. 1995;149:1113-1117.
46. Hoberman A, Greenberg DP, Paradise JL, et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. JAMA. 2003;290:1608-1616.
47. Heikkinen T, Ruuskanen O. Effectiveness of influenza vaccine to prevent acute otitis media. JAMA. 2004;291:692-693; author reply 693.
48. Block SL, Heikkinen T, Toback SL, et al. The efficacy of live attenuated influenza vaccine against influenza-associated acute otitis media in children. Pediatr Infect Dis J. 2011;30:203-207.
49. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179-186.
50. Bhat N, Wright JG, Broder KR, et al. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med. 2005;353:2559-2567.
51. Reichert TA, Sugaya N, Fedson DS, et al. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med. 2001;344:889-896.
52. Loeb M, Russell ML, Moss L, et al. Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA. 2010;303:943-950.
53. Esposito S, Cantarutti L, Molteni CG, et al. Clinical manifestations and socio-economic impact of influenza among healthy children in the community. J Infect. 2011;62:379-387.
54. Tsolia MN, Logotheti I, Papadopoulos NG, et al.; Outpatient Flu Study Group. Impact of influenza infection in healthy children examined as outpatients and their families. Vaccine. 2006;24:5970-5976.
55. Shuler CM, Iwamoto M, Bridges CB, et al. Vaccine effectiveness against medically attended, laboratory-confirmed influenza among children aged 6 to 59 months, 2003-2004. Pediatrics. 2007;119:e587-e595.
56. Szilagyi PG, Fairbrother G, Griffin MR, et al. Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons. Arch Pediatr Adolesc Med. 2008;162:943-951.
57. Eisenberg KW, Szilagyi PG, Fairbrother G, et al. Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons. Pediatrics. 2008;122:911-919.
58. Joshi AY, Iyer VN, St Sauver JL, et al. Effectiveness of inactivated influenza vaccine in children less than 5 years of age over multiple influenza seasons: a case-control study. Vaccine. 2009;27:4457-4461.
59. Cochran LW, Black S, Klein NP, et al. Vaccine effectiveness against laboratory-confirmed influenza in infants: A matched case control study. Hum Vaccin. 2010;6:729-735.
60. Heinonen S, Silvennoinen H, Lehtinen P, et al. Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study. Lancet Infect Dis. 2011;11:23-29.
61. Katayose M, Hosoya M, Haneda T, et al. The effectiveness of trivalent inactivated influenza vaccine in children over six consecutive influenza seasons. Vaccine. 2011;29:1844-1849.
62. Kelly H, Jacoby P, Dixon GA, et al.; WAIVE Study Team. Vaccine effectiveness against laboratory-confirmed influenza in healthy young children: a case-control study. Pediatr Infect Dis J. 2011;30:107-111.
63. Vesikari T, Knuf M, Wutzler P, et al. Oil-in-water emulsion adjuvant with influenza vaccine in young children. N Engl J Med. 2011;365:1406-1416.
64. Treanor JJ, Talbot HK, Ohmit SE, et al.; US Flu-VE Network. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis. 2012;55:951-959.
65. Belongia EA, Kieke BA, Donahue JG, et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis. 2009;199:159-167.
66. Skowronski DM, De Serres G, Dickinson J, et al. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis. 2009;199:168-179.
67. Beran J, Wertzova V, Honegr K, et al. Challenge of conducting a placebocontrolled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example. BMC Infect Dis. 2009;9:2.
68. Jefferson T, Rivetti A, Di Pietrantonj C, et al. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev. 2012;8:CD004879.
69. Heikkinen T, Heinonen S. Influenza vaccine in young children. N Engl J Med. 2012;366:383; author reply 383-383; author reply 384.
70. Skowronski DM, Hottes TS, Chong M, et al. Randomized controlled trial of dose response to influenza vaccine in children aged 6 to 23 months. Pediatrics. 2011;128:e276-e289.
71. Black S, Nicolay U, Vesikari T, et al. Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children. Pediatr Infect Dis J. 2011;30:1081-1085.
72. Esposito S, Marchisio P, Ansaldi F, et al. A randomized clinical trial assessing immunogenicity and safety of a double dose of virosomal-adjuvanted influenza vaccine administered to unprimed children aged 6-35 months. Vaccine. 2010;28:6137-6144.
73. Reed C, Meltzer MI, Finelli L, et al. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine. Vaccine. 2012;30:1993-1998.
74. Rhorer J, Ambrose CS, Dickinson S, et al. Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials. Vaccine. 2009;27:1101-1110.
75. Belshe RB, Edwards KM, Vesikari T, et al.; CAIV-T Comparative Efficacy Study Group. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med. 2007;356:685-696.
76. France EK, Glanz JM, Xu S, et al. Safety of the trivalent inactivated influenza vaccine among children. Arch Pediatr Adolesc Med. 2004;158:1031-1036.
77. Burwen DR, Sandhu SK, MaCurdy TE, et al. Surveillance for Guillain-Barré syndrome after influenza vaccination among the Medicare population, 2009-2010. Am J Public Health. 2012;102:1921-1927.
78. Kelso JM. Safety of influenza vaccines. Curr Opin Allergy Clin Immunol. 2012;12:383-388.
79. Nohynek H, Jokinen J, Partinen M, et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One. 2012;7:e33536.
80. National Narcolepsy Study Steering Committee. Investigation of an increase in the incidence of narcolepsy in children and adolescents in 2009 and 2010. Available at: http://healthupdate.gov.ie/wp-content/uploads/2012/04/Final- Report-of-National-Narcolepsy-Study-Steering-Committee-latest1.pdf Accessed February 26, 2013.
81. Miller E, Andrews N, Stellitano L, et al. Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis. BMJ. 2013;346:f794.
82. Ambrose CS, Yi T, Falloon J. An integrated, multistudy analysis of the safety of Ann Arbor strain live attenuated influenza vaccine in children aged 2-17 years. Influenza Other Respi Viruses. 2011;5:389-397.
83. Bodewes R, Fraaij PL, Kreijtz JH, et al. Annual influenza vaccination affects the development of heterosubtypic immunity. Vaccine. 2012;30:7407-7410.
84. Heikkinen T, Peltola V. Influenza vaccination of children. Lancet Infect Dis. 2009;9:720-721.
85. Viboud C, Simonsen L. Does seasonal influenza vaccination increase the risk of illness with the 2009 A/H1N1 pandemic virus? PLoS Med. 2010;7:e1000259.
86. Cowling BJ, Ng S, Ma ES, et al. Protective efficacy against pandemic influenza of seasonal influenza vaccination in children in Hong Kong: a randomized controlled trial. Clin Infect Dis. 2012;55:695-702.
87. Effler PV. Every year is an influenza pandemic for children: can we stop them? Pediatrics. 2012;130:554-556.
88. Monto AS, Davenport FM, Napier JA, et al. Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren. J Infect Dis. 1970;122:16-25.
89. Jordan R, Connock M, Albon E, et al. Universal vaccination of children against influenza: are there indirect benefits to the community? A systematic review of the evidence. Vaccine. 2006;24:1047-1062.
90. Hurwitz ES, Haber M, Chang A, et al. Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA. 2000;284:1677-1682.
91. Esposito S, Marchisio P, Cavagna R, et al. Effectiveness of influenza vaccination of children with recurrent respiratory tract infections in reducing respiratory-related morbidity within the households. Vaccine. 2003;21:3162-3168.
92. Pitman RJ, White LJ, Sculpher M. Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales. Vaccine. 2012;30:1208-1224.
93. Nichol KL. Cost-effectiveness and socio-economic aspects of childhood influenza vaccination. Vaccine. 2011;29:7554-7558.
94. Molinari NA, Ortega-Sanchez IR, Messonnier ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007;25:5086-5096.
95. Salo H, Kilpi T, Sintonen H, et al. Cost-effectiveness of influenza vaccination of healthy children. Vaccine. 2006;24:4934-4941.
96. Esposito S, Marchisio P, Bosis S, et al. Clinical and economic impact of influenza vaccination on healthy children aged 2-5 years. Vaccine. 2006;24:629-635.
97. Marchetti M, Kühnel UM, Colombo GL, et al. Cost-effectiveness of adjuvanted influenza vaccination of healthy children 6 to 60 months of age. Hum Vaccin. 2007;3:14-22.
98. de Kok IM, van Ballegooijen M, Habbema JD. Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands. J Natl Cancer Inst. 2009;101:1083-1092.
99. National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal, June 2008. Available at: http://www.nice.org. uk/media/B52/A7/TA MethodsGuideUpdatedJune2008.pdf Accessed February 26, 2013.
100. Navas E, Salleras L, Domínguez A, et al. Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3-14 years from the provider and societal perspectives. Vaccine. 2007;25: 3233-3239.
101. Antonova EN, Rycroft CE, Ambrose CS, et al. Burden of paediatric influenza in Western Europe: a systematic review. BMC Public Health. 2012;12:968.
102. Fiore AE, Epperson S, Perrotta D, et al. Expanding the recommendations for annual influenza vaccination to school-age children in the United States. Pediatrics. 2012;129(suppl 2):S54-S62.
103. Hawkes N. Too few school nurses to administer proposed flu vaccination programme, experts say. BMJ. 2012;345:e5108.
104. Poland GA. Putting the puzzle pieces together: the dynamic landscape of influenza vaccine and policy. Vaccine. 2010;28(suppl 4):D1-D2.
105. Lambert LC, Fauci AS. Influenza vaccines for the future. N Engl J Med. 2010;363:2036-2044.